CADTH recommends reimbursement for weight management in adult and pediatric patients six years of age and older with obesity due to Bardet-Biedl syndrome (BBS) --
-- Recommendation based on demonstrated clinical benefit in Phase 3 trial --
https://www.globenewswire.com/news-release/2023/11/02/2772213/0/en/Rhythm-Pharmaceuticals-Receives-Positive-CADTH-Reimbursement-Recommendation-for-IMCIVREE-setmelanotide.html
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.